CBD effective in treating symptoms of schizophrenia
Approximately 0.5% of the population are diagnosed with some form of schizophrenia, a highly stigmatized and, if untreated, debilitating psychiatric condition. ENFLEUR is happy to promote a recent review published by the evidence-based journal, Medicines, showing that phytocannabinoid consumption may be “a safe and effective treatment option for schizophrenia as a primary or adjunctive therapy”. This conclusion is based on the literature reviewed, which shows that psychosis is almost always accompanied by inflammation and the activation of the central nervous system immune system. CBD is a proven anti-inflammatory, and with the potential importance of the endocannabinoid system in modulating immune system response, CBD is viewed optimistically with good reason as an alternative to “ill-tolerated antipsychotics with debilitating side effects”. Though the majority of the population may not contend with psychosis, CBD has also been positively associated with decreasing the symptoms of PTSD, as well as various forms of anxiety and panic disorders. For this reason, it is reasonable to consider integrating a high quality CBD supplement into a daily wellness routine.
Why does this matter? A recent literature review has found that CBD may be a safe and effective treatment option for psychosis in the treatment of schizophrenia.